English  |  正體中文  |  简体中文  |  全文筆數/總筆數 : 18034/20233 (89%)
造訪人次 : 23776436      線上人數 : 736
RC Version 7.0 © Powered By DSPACE, MIT. Enhanced by NTU Library IR team.
搜尋範圍 查詢小技巧:
  • 您可在西文檢索詞彙前後加上"雙引號",以獲取較精準的檢索結果
  • 若欲以作者姓名搜尋,建議至進階搜尋限定作者欄位,可獲得較完整資料
  • 進階搜尋
    請使用永久網址來引用或連結此文件: https://ir.cnu.edu.tw/handle/310902800/34330


    標題: Lipid Metabolism and its Mechanism Triggered by Supercritical CO2 Extract of Adlay (Coix lacryma-jobi var. ma-yuen (Rom. Caill.) Stapf) Bran in High-Fat Diet Induced Hyperlipidemic Hamsters
    作者: Huang, Chiao-Chih
    Lin, Tzu-Ching
    Liu, Chiung-Hui
    Hu, Hao-Chun
    Yu, Szu-Yin
    Wu, Shu-Jing
    Yen, Ming-Hong
    Tsai, Yi-Hong
    Chang, Fang-Rong
    貢獻者: Kaohsiung Med Univ, Grad Inst Nat Prod, Coll Pharm
    Chia Nan Univ Pharm & Sci, Dept Nutr Hlth
    Tajen Univ, Coll Pharm & Hlth Care, Dept Pharm
    Tajen Univ, Coll Pharm & Hlth Care, Master Program
    Kaohsiung Med Univ, Drug Dev & Value Creat Res Ctr
    Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Dept Med Res
    Natl Sun Yat Sen Univ, Dept Marine Biotechnol & Resources
    關鍵字: adlay bran
    supercritical fluid extract
    hypolipidemic capacity
    unsaturated fatty acids (UFAs)
    ferulate phytostanol esters
    日期: 2021
    上傳時間: 2023-11-11 11:44:03 (UTC+8)
    出版者: FRONTIERS MEDIA SA
    摘要: Adlay (Coix lacryma-jobi var. ma-yuen (Rom. Caill.) Stapf) seeds are edible crop classified as Traditional Chinese Medicine (TCM). Adlay bran (AB) is one of the wastes generated during adlay refining processes. In this work, supercritical fluid extract of AB (AB-SCF) was investigated to reveal its lipid regulating potential and decode its bifunctional ingredients. AB-SCFx0.5 (30.84 mg/kg/body weight), AB-SCFx1 (61.67 mg/kg/BW), AB-SCFx5 (308.35 mg/kg/BW) and AB-SCFx10 (616.70 mg/kg/BW) were administrated to high fat-diet (HFD) induced hyperglycemic hamsters for 8 weeks. The results indicates that AB-SCF displays a prevention of dramatic body weight gains, lower levels of serum TG, TC, LDL-C and higher in HDL-C, amelioration of cardiovascular risk, alleviation of hepatic TG, TC and lipid peroxidation, and enhancement on cholesterol metabolism with higher bile acid excretion. Investigations on energy metabolic mechanism demonstrates that the hyperlipidemia mitigating capacities of AB-SCF are up-regulated on lipoprotein lipase, AMPK, p-AMPK and down-regulated at fatty acid synthase. Major bio-functional lipid compositions are identified as linoleic acid (28.59%) and oleic acid (56.95%). Non-lipid chemical and active markers are confirmed as 3-O-(trans-4-feruloyl)-beta-sitostanol (1463.42 ppm), 3-O-(cis-4-feruloyl)-beta-sitostanol (162.60 ppm), and beta-sitosterol (4117.72 ppm). These compositions might synergistically responsible for the mentioned activities and can be regarded as analytical targets in quality control. AB-SCF may be considered as a promising complementary supplement, and developed as a functional food or new botanical drug in the future.
    關聯: FRONT PHARMACOL, v.12, pp.785944
    顯示於類別:[保健營養系(所) ] 期刊論文

    文件中的檔案:

    檔案 描述 大小格式瀏覽次數
    fphar.2021.785944.pdf2271KbAdobe PDF43檢視/開啟
    index.html0KbHTML85檢視/開啟


    在CNU IR中所有的資料項目都受到原著作權保護.

    TAIR相關文章

    DSpace Software Copyright © 2002-2004  MIT &  Hewlett-Packard  /   Enhanced by   NTU Library IR team Copyright ©   - 回饋